DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $224,563,657 | -24.7% | 10,885,296 | +7.7% | 0.01% | -25.0% |
| Q2 2023 | $298,236,175 | +36.6% | 10,106,275 | +6.7% | 0.01% | +33.3% |
| Q1 2023 | $218,290,108 | -15.8% | 9,474,397 | +1.6% | 0.01% | -25.0% |
| Q4 2022 | $259,245,210 | -1.8% | 9,322,014 | +8.4% | 0.01% | -11.1% |
| Q3 2022 | $263,880,000 | +2.1% | 8,598,212 | -2.1% | 0.01% | +12.5% |
| Q2 2022 | $258,532,000 | -1.8% | 8,784,632 | +7.3% | 0.01% | +14.3% |
| Q1 2022 | $263,336,000 | -27.2% | 8,185,740 | +0.9% | 0.01% | -22.2% |
| Q4 2021 | $361,741,000 | -5.2% | 8,110,822 | +7.3% | 0.01% | -18.2% |
| Q3 2021 | $381,444,000 | -30.9% | 7,560,837 | +7.5% | 0.01% | -26.7% |
| Q2 2021 | $551,906,000 | +47.2% | 7,036,041 | +7.2% | 0.02% | +36.4% |
| Q1 2021 | $374,830,000 | -29.8% | 6,564,452 | +3.0% | 0.01% | -35.3% |
| Q4 2020 | $534,062,000 | +144.9% | 6,376,078 | +4.8% | 0.02% | +112.5% |
| Q3 2020 | $218,036,000 | +44.1% | 6,085,317 | -2.8% | 0.01% | +33.3% |
| Q2 2020 | $151,309,000 | +64.1% | 6,257,582 | +18.8% | 0.01% | +20.0% |
| Q1 2020 | $92,213,000 | +0.9% | 5,266,356 | +0.4% | 0.01% | +25.0% |
| Q4 2019 | $91,410,000 | +13.7% | 5,247,578 | +0.0% | 0.00% | +33.3% |
| Q3 2019 | $80,382,000 | -24.9% | 5,246,909 | +1.8% | 0.00% | -40.0% |
| Q2 2019 | $106,999,000 | +1.3% | 5,154,097 | +13.3% | 0.01% | 0.0% |
| Q1 2019 | $105,634,000 | +11.8% | 4,549,331 | -0.5% | 0.01% | 0.0% |
| Q4 2018 | $94,469,000 | +31.4% | 4,572,695 | +38.3% | 0.01% | +66.7% |
| Q3 2018 | $71,896,000 | +320.4% | 3,307,050 | +194.9% | 0.00% | +200.0% |
| Q2 2018 | $17,101,000 | -17.6% | 1,121,358 | +6.4% | 0.00% | 0.0% |
| Q1 2018 | $20,753,000 | – | 1,053,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |